ATLASMangoceuticals (MGRX) earnings date: Nov 13, 2026
Mangoceuticals (MGRX) reports earnings for the quarter ended Sep 30, 2026 on Fri, Nov 13, 2026.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on MGRX
| Last price | $0.23 (-1.8%) |
|---|---|
| Normal 1-day range (±1σ) | ±7.2% |
| Earnings beat history | Beat the EPS estimate in 4 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Mangoceuticals stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Mangoceuticals reports on Nov 13, 2026. One email the day before, with ATLAS’s read on Mangoceuticals. You can switch it off at any time.
Alert me before MGRX reportsFree to start. Creating an account takes under a minute.
Notify me when Mangoceuticals reports
Track MGRX free Add Mangoceuticals to a free ATLAS watchlist and see its next report date in one place.
MGRX earnings at a glance
| Next report (confirmed) | Fri, Nov 13, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| Last report | Jun 29, 2026 · Beat |
| Beat rate (last 4 reports) | 4 of 4 (100%) |
| Average EPS surprise | +33.3% |
| Average move around a report | ±7.1% (last 4) |
| Sector | Healthcare · Health Information Services |
Mangoceuticals earnings history: last 4 reports
Mangoceuticals last reported on Jun 29, 2026: EPS of -$0.02 against an estimate of -$0.11 (+81.8% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Jun 29, 2026 | -$0.11 | -$0.02 | +81.8% | Beat | +1.1% |
| Jun 1, 2026 | $2.28 | $3.23 | +41.7% | Beat | -10.9% |
| Feb 26, 2026 | $0.32 | $0.34 | +6.3% | Beat | +7.0% |
| Oct 31, 2025 | $1.77 | $1.83 | +3.4% | Beat | -9.3% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for MGRX
See the fair value, the probability range and the earnings history of Mangoceuticals on its ATLAS page.
Mangoceuticals (MGRX) stock analysisPlans from €3.99 a month.
Mangoceuticals earnings: frequently asked questions
When does Mangoceuticals (MGRX) report earnings?
Mangoceuticals is scheduled to report on Friday, November 13, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
How often does MGRX beat earnings estimates?
Of its last 4 reports with a recorded result, Mangoceuticals beat the EPS estimate 4 times; the average surprise was +33.3%. Past results do not predict the next one.
How much does MGRX move around earnings?
Over its last 4 reports the stock moved an average of 7.1% (absolute, from the close before the report day to the close after it), and finished higher 2 of 4 times.
Did Mangoceuticals beat earnings estimates last quarter?
Mangoceuticals last reported on Jun 29, 2026: EPS of -$0.02 against an estimate of -$0.11 (+81.8% surprise), a beat.
How much does MGRX usually move in a day?
On a normal trading day the ATLAS model puts MGRX’s one-day range at about ±7.2%, with a 48% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Fri, Nov 13, 2026
Educational information, not investment advice. Disclaimer